APO Research
Talk to an analyst

APO RESEARCH · REPORT

SNP Microarray Testing and Analysis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global SNP Microarray Testing and Analysis Market Outlook and Growth Opportunities 2026

28 December 2025203 pages

Choose your research edition.

Industry ResearchSNP Microarray Testing and Analysis Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal SNP Microarray Testing and Analysis Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal SNP Microarray Testing and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal SNP Microarray Testing and Analysis Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal SNP Microarray Testing and Analysis Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global SNP Microarray Testing and Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for SNP Microarray Testing and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for SNP Microarray Testing and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for SNP Microarray Testing and Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the SNP Microarray Testing and Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the SNP Microarray Testing and Analysis market include Thermo Fisher Scientific, Illumina, Agilent, Roche, Bio-Rad, CD Genomics, Ambry Genetics, Labcorp and Allele Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global SNP Microarray Testing and Analysis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of SNP Microarray Testing and Analysis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents SNP Microarray Testing and Analysis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global SNP Microarray Testing and Analysis market.

SNP Microarray Testing and Analysis Segment by Company

Thermo Fisher Scientific

Illumina

Agilent

Roche

Bio-Rad

CD Genomics

Ambry Genetics

Labcorp

Allele Diagnostics

Sonic Genetics

Invitae

Genetics Generation Advancement (GGA)

Quest Diagnostics

CapitalBio

HNL Lab Medicine

Psomagen

VCGS

Genetics Associates

SNP Microarray Testing and Analysis Segment by Type

Whole Genome SNP Microarrays

Custom SNP Microarrays

SNP Microarray Testing and Analysis Segment by Application

Pharmaceuticals and Pharmacogenomics

Diagnostic Research

Agricultural Biotechnology

Other

SNP Microarray Testing and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global SNP Microarray Testing and Analysis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the SNP Microarray Testing and Analysis key companies, revenue, market share, and recent developments.

3. To split the SNP Microarray Testing and Analysis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions SNP Microarray Testing and Analysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify SNP Microarray Testing and Analysis significant trends, drivers, influence factors in global and regions.

6. To analyze SNP Microarray Testing and Analysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SNP Microarray Testing and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of SNP Microarray Testing and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SNP Microarray Testing and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global SNP Microarray Testing and Analysis industry.

Chapter 3: Detailed analysis of SNP Microarray Testing and Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of SNP Microarray Testing and Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of SNP Microarray Testing and Analysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. SNP Microarray Testing and Analysis Industry Trends Table 2. SNP Microarray Testing and Analysis Industry Drivers Table 3. SNP Microarray Testing and Analysis Industry Opportunities and Challenges Table 4. SNP Microarray Testing and Analysis Industry Restraints Table 5. Global SNP Microarray Testing and Analysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global SNP Microarray Testing and Analysis Revenue Share by Company (2021-2026) Table 7. Global SNP Microarray Testing and Analysis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global SNP Microarray Testing and Analysis Key Company Manufacturing Base & Headquarters Table 9. Global SNP Microarray Testing and Analysis Company, Product Type & Application Table 10. Global SNP Microarray Testing and Analysis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global SNP Microarray Testing and Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Whole Genome SNP Microarrays Table 15. Significant Companies of Custom SNP Microarrays Table 16. Global SNP Microarray Testing and Analysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global SNP Microarray Testing and Analysis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global SNP Microarray Testing and Analysis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global SNP Microarray Testing and Analysis Sales Value Share by Type (2021-2026) Table 20. Global SNP Microarray Testing and Analysis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceuticals and Pharmacogenomics Table 22. Significant Companies of Diagnostic Research Table 23. Significant Companies of Agricultural Biotechnology Table 24. Significant Companies of Other Table 25. Global SNP Microarray Testing and Analysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global SNP Microarray Testing and Analysis Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global SNP Microarray Testing and Analysis Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global SNP Microarray Testing and Analysis Sales Value Share by Application (2021-2026) Table 29. Global SNP Microarray Testing and Analysis Sales Value Share by Application (2027-2032) Table 30. Global SNP Microarray Testing and Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global SNP Microarray Testing and Analysis Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global SNP Microarray Testing and Analysis Sales Value Share by Region (2021-2026) Table 33. Global SNP Microarray Testing and Analysis Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global SNP Microarray Testing and Analysis Sales Value Share by Region (2027-2032) Table 35. Global SNP Microarray Testing and Analysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global SNP Microarray Testing and Analysis Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global SNP Microarray Testing and Analysis Sales Value Market Share by Country (2021-2026) Table 38. Global SNP Microarray Testing and Analysis Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global SNP Microarray Testing and Analysis Sales Value Market Share by Country (2027-2032) Table 40. Thermo Fisher Scientific Company Information Table 41. Thermo Fisher Scientific Business Overview Table 42. Thermo Fisher Scientific SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Thermo Fisher Scientific SNP Microarray Testing and Analysis Product Portfolio Table 44. Thermo Fisher Scientific Recent Development Table 45. Illumina Company Information Table 46. Illumina Business Overview Table 47. Illumina SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Illumina SNP Microarray Testing and Analysis Product Portfolio Table 49. Illumina Recent Development Table 50. Agilent Company Information Table 51. Agilent Business Overview Table 52. Agilent SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Agilent SNP Microarray Testing and Analysis Product Portfolio Table 54. Agilent Recent Development Table 55. Roche Company Information Table 56. Roche Business Overview Table 57. Roche SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Roche SNP Microarray Testing and Analysis Product Portfolio Table 59. Roche Recent Development Table 60. Bio-Rad Company Information Table 61. Bio-Rad Business Overview Table 62. Bio-Rad SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Bio-Rad SNP Microarray Testing and Analysis Product Portfolio Table 64. Bio-Rad Recent Development Table 65. CD Genomics Company Information Table 66. CD Genomics Business Overview Table 67. CD Genomics SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. CD Genomics SNP Microarray Testing and Analysis Product Portfolio Table 69. CD Genomics Recent Development Table 70. Ambry Genetics Company Information Table 71. Ambry Genetics Business Overview Table 72. Ambry Genetics SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Ambry Genetics SNP Microarray Testing and Analysis Product Portfolio Table 74. Ambry Genetics Recent Development Table 75. Labcorp Company Information Table 76. Labcorp Business Overview Table 77. Labcorp SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Labcorp SNP Microarray Testing and Analysis Product Portfolio Table 79. Labcorp Recent Development Table 80. Allele Diagnostics Company Information Table 81. Allele Diagnostics Business Overview Table 82. Allele Diagnostics SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Allele Diagnostics SNP Microarray Testing and Analysis Product Portfolio Table 84. Allele Diagnostics Recent Development Table 85. Sonic Genetics Company Information Table 86. Sonic Genetics Business Overview Table 87. Sonic Genetics SNP Microarray Testing and Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sonic Genetics SNP Microarray Testing and Analysis Product Portfolio Table 89. Sonic Genetics Recent Development Table 90. Invitae Company Information Table 91. Invitae Business Overview Table 92. Invitae SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Invitae SNP Microarray Testing and Analysis Product Portfolio Table 94. Invitae Recent Development Table 95. Genetics Generation Advancement (GGA) Company Information Table 96. Genetics Generation Advancement (GGA) Business Overview Table 97. Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Product Portfolio Table 99. Genetics Generation Advancement (GGA) Recent Development Table 100. Quest Diagnostics Company Information Table 101. Quest Diagnostics Business Overview Table 102. Quest Diagnostics SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Quest Diagnostics SNP Microarray Testing and Analysis Product Portfolio Table 104. Quest Diagnostics Recent Development Table 105. CapitalBio Company Information Table 106. CapitalBio Business Overview Table 107. CapitalBio SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. CapitalBio SNP Microarray Testing and Analysis Product Portfolio Table 109. CapitalBio Recent Development Table 110. HNL Lab Medicine Company Information Table 111. HNL Lab Medicine Business Overview Table 112. HNL Lab Medicine SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. HNL Lab Medicine SNP Microarray Testing and Analysis Product Portfolio Table 114. HNL Lab Medicine Recent Development Table 115. Psomagen Company Information Table 116. Psomagen Business Overview Table 117. Psomagen SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Psomagen SNP Microarray Testing and Analysis Product Portfolio Table 119. Psomagen Recent Development Table 120. VCGS Company Information Table 121. VCGS Business Overview Table 122. VCGS SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. VCGS SNP Microarray Testing and Analysis Product Portfolio Table 124. VCGS Recent Development Table 125. Genetics Associates Company Information Table 126. Genetics Associates Business Overview Table 127. Genetics Associates SNP Microarray Testing and Analysis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Genetics Associates SNP Microarray Testing and Analysis Product Portfolio Table 129. Genetics Associates Recent Development Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. SNP Microarray Testing and Analysis Product Image Figure 2. Global SNP Microarray Testing and Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global SNP Microarray Testing and Analysis Market Size (2021-2032) & (US$ Million) Figure 4. Global SNP Microarray Testing and Analysis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Whole Genome SNP Microarrays Image Figure 8. Custom SNP Microarrays Image Figure 9. Global SNP Microarray Testing and Analysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global SNP Microarray Testing and Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global SNP Microarray Testing and Analysis Sales Value Share by Type (2021-2032) Figure 12. Pharmaceuticals and Pharmacogenomics Image Figure 13. Diagnostic Research Image Figure 14. Agricultural Biotechnology Image Figure 15. Other Image Figure 16. Global SNP Microarray Testing and Analysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global SNP Microarray Testing and Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global SNP Microarray Testing and Analysis Sales Value Share by Application (2021-2032) Figure 19. Global SNP Microarray Testing and Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global SNP Microarray Testing and Analysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America SNP Microarray Testing and Analysis Sales Value (2021-2032) & (US$ Million) Figure 22. North America SNP Microarray Testing and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe SNP Microarray Testing and Analysis Sales Value (2021-2032) & (US$ Million) Figure 24. Europe SNP Microarray Testing and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific SNP Microarray Testing and Analysis Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific SNP Microarray Testing and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America SNP Microarray Testing and Analysis Sales Value (2021-2032) & (US$ Million) Figure 28. South America SNP Microarray Testing and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa SNP Microarray Testing and Analysis Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa SNP Microarray Testing and Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Genome SNP Microarrays
  • Custom SNP Microarrays
Applications
  • Pharmaceuticals and Pharmacogenomics
  • Diagnostic Research
  • Agricultural Biotechnology
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Illumina
  • Agilent
  • Roche
  • Bio-Rad
  • CD Genomics
  • Ambry Genetics
  • Labcorp
  • Allele Diagnostics
  • Sonic Genetics
  • Invitae
  • Genetics Generation Advancement (GGA)
  • Quest Diagnostics
  • CapitalBio
  • HNL Lab Medicine
  • Psomagen
  • VCGS
  • Genetics Associates

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global SNP Microarray Testing and Analysis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global SNP Microarray Testing and Analysis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 SNP Microarray Testing and Analysis Market Dynamics
  1. 2.1 SNP Microarray Testing and Analysis Industry Trends
  2. 2.2 SNP Microarray Testing and Analysis Industry Drivers
  3. 2.3 SNP Microarray Testing and Analysis Industry Opportunities and Challenges
  4. 2.4 SNP Microarray Testing and Analysis Industry Restraints
3 SNP Microarray Testing and Analysis Market by Company
  1. 3.1 Global SNP Microarray Testing and Analysis Company Revenue Ranking in 2025
  2. 3.2 Global SNP Microarray Testing and Analysis Revenue by Company (2021-2026)
  3. 3.3 Global SNP Microarray Testing and Analysis Company Ranking (2024-2026)
  4. 3.4 Global SNP Microarray Testing and Analysis Company Manufacturing Base and Headquarters
  5. 3.5 Global SNP Microarray Testing and Analysis Company Product Type and Application
  6. 3.6 Global SNP Microarray Testing and Analysis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global SNP Microarray Testing and Analysis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 SNP Microarray Testing and Analysis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 SNP Microarray Testing and Analysis Market by Type
  1. 4.1 SNP Microarray Testing and Analysis Type Introduction
  2. 4.1.1 Whole Genome SNP Microarrays
  3. 4.1.2 Custom SNP Microarrays
  4. 4.2 Global SNP Microarray Testing and Analysis Sales Value by Type
  5. 4.2.1 Global SNP Microarray Testing and Analysis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global SNP Microarray Testing and Analysis Sales Value by Type (2021-2032)
  7. 4.2.3 Global SNP Microarray Testing and Analysis Sales Value Share by Type (2021-2032)
5 SNP Microarray Testing and Analysis Market by Application
  1. 5.1 SNP Microarray Testing and Analysis Application Introduction
  2. 5.1.1 Pharmaceuticals and Pharmacogenomics
  3. 5.1.2 Diagnostic Research
  4. 5.1.3 Agricultural Biotechnology
  5. 5.1.4 Other
  6. 5.2 Global SNP Microarray Testing and Analysis Sales Value by Application
  7. 5.2.1 Global SNP Microarray Testing and Analysis Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global SNP Microarray Testing and Analysis Sales Value by Application (2021-2032)
  9. 5.2.3 Global SNP Microarray Testing and Analysis Sales Value Share by Application (2021-2032)
6 SNP Microarray Testing and Analysis Regional Value Analysis
  1. 6.1 Global SNP Microarray Testing and Analysis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global SNP Microarray Testing and Analysis Sales Value by Region (2021-2032)
  3. 6.2.1 Global SNP Microarray Testing and Analysis Sales Value by Region: 2021-2026
  4. 6.2.2 Global SNP Microarray Testing and Analysis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America SNP Microarray Testing and Analysis Sales Value (2021-2032)
  7. 6.3.2 North America SNP Microarray Testing and Analysis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe SNP Microarray Testing and Analysis Sales Value (2021-2032)
  10. 6.4.2 Europe SNP Microarray Testing and Analysis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific SNP Microarray Testing and Analysis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific SNP Microarray Testing and Analysis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America SNP Microarray Testing and Analysis Sales Value (2021-2032)
  16. 6.6.2 South America SNP Microarray Testing and Analysis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa SNP Microarray Testing and Analysis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa SNP Microarray Testing and Analysis Sales Value Share by Country, 2025 VS 2032
7 SNP Microarray Testing and Analysis Country-level Value Analysis
  1. 7.1 Global SNP Microarray Testing and Analysis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global SNP Microarray Testing and Analysis Sales Value by Country (2021-2032)
  3. 7.2.1 Global SNP Microarray Testing and Analysis Sales Value by Country (2021-2026)
  4. 7.2.2 Global SNP Microarray Testing and Analysis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt SNP Microarray Testing and Analysis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt SNP Microarray Testing and Analysis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt SNP Microarray Testing and Analysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific SNP Microarray Testing and Analysis Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Illumina
  8. 8.2.1 Illumina Company Information
  9. 8.2.2 Illumina Business Overview
  10. 8.2.3 Illumina SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Illumina SNP Microarray Testing and Analysis Product Portfolio
  12. 8.2.5 Illumina Recent Developments
  13. 8.3 Agilent
  14. 8.3.1 Agilent Company Information
  15. 8.3.2 Agilent Business Overview
  16. 8.3.3 Agilent SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Agilent SNP Microarray Testing and Analysis Product Portfolio
  18. 8.3.5 Agilent Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche SNP Microarray Testing and Analysis Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Bio-Rad
  26. 8.5.1 Bio-Rad Company Information
  27. 8.5.2 Bio-Rad Business Overview
  28. 8.5.3 Bio-Rad SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad SNP Microarray Testing and Analysis Product Portfolio
  30. 8.5.5 Bio-Rad Recent Developments
  31. 8.6 CD Genomics
  32. 8.6.1 CD Genomics Company Information
  33. 8.6.2 CD Genomics Business Overview
  34. 8.6.3 CD Genomics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CD Genomics SNP Microarray Testing and Analysis Product Portfolio
  36. 8.6.5 CD Genomics Recent Developments
  37. 8.7 Ambry Genetics
  38. 8.7.1 Ambry Genetics Company Information
  39. 8.7.2 Ambry Genetics Business Overview
  40. 8.7.3 Ambry Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ambry Genetics SNP Microarray Testing and Analysis Product Portfolio
  42. 8.7.5 Ambry Genetics Recent Developments
  43. 8.8 Labcorp
  44. 8.8.1 Labcorp Company Information
  45. 8.8.2 Labcorp Business Overview
  46. 8.8.3 Labcorp SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Labcorp SNP Microarray Testing and Analysis Product Portfolio
  48. 8.8.5 Labcorp Recent Developments
  49. 8.9 Allele Diagnostics
  50. 8.9.1 Allele Diagnostics Company Information
  51. 8.9.2 Allele Diagnostics Business Overview
  52. 8.9.3 Allele Diagnostics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Allele Diagnostics SNP Microarray Testing and Analysis Product Portfolio
  54. 8.9.5 Allele Diagnostics Recent Developments
  55. 8.10 Sonic Genetics
  56. 8.10.1 Sonic Genetics Company Information
  57. 8.10.2 Sonic Genetics Business Overview
  58. 8.10.3 Sonic Genetics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sonic Genetics SNP Microarray Testing and Analysis Product Portfolio
  60. 8.10.5 Sonic Genetics Recent Developments
  61. 8.11 Invitae
  62. 8.11.1 Invitae Company Information
  63. 8.11.2 Invitae Business Overview
  64. 8.11.3 Invitae SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Invitae SNP Microarray Testing and Analysis Product Portfolio
  66. 8.11.5 Invitae Recent Developments
  67. 8.12 Genetics Generation Advancement (GGA)
  68. 8.12.1 Genetics Generation Advancement (GGA) Company Information
  69. 8.12.2 Genetics Generation Advancement (GGA) Business Overview
  70. 8.12.3 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Product Portfolio
  72. 8.12.5 Genetics Generation Advancement (GGA) Recent Developments
  73. 8.13 Quest Diagnostics
  74. 8.13.1 Quest Diagnostics Company Information
  75. 8.13.2 Quest Diagnostics Business Overview
  76. 8.13.3 Quest Diagnostics SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Quest Diagnostics SNP Microarray Testing and Analysis Product Portfolio
  78. 8.13.5 Quest Diagnostics Recent Developments
  79. 8.14 CapitalBio
  80. 8.14.1 CapitalBio Company Information
  81. 8.14.2 CapitalBio Business Overview
  82. 8.14.3 CapitalBio SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CapitalBio SNP Microarray Testing and Analysis Product Portfolio
  84. 8.14.5 CapitalBio Recent Developments
  85. 8.15 HNL Lab Medicine
  86. 8.15.1 HNL Lab Medicine Company Information
  87. 8.15.2 HNL Lab Medicine Business Overview
  88. 8.15.3 HNL Lab Medicine SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  89. 8.15.4 HNL Lab Medicine SNP Microarray Testing and Analysis Product Portfolio
  90. 8.15.5 HNL Lab Medicine Recent Developments
  91. 8.16 Psomagen
  92. 8.16.1 Psomagen Company Information
  93. 8.16.2 Psomagen Business Overview
  94. 8.16.3 Psomagen SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Psomagen SNP Microarray Testing and Analysis Product Portfolio
  96. 8.16.5 Psomagen Recent Developments
  97. 8.17 VCGS
  98. 8.17.1 VCGS Company Information
  99. 8.17.2 VCGS Business Overview
  100. 8.17.3 VCGS SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  101. 8.17.4 VCGS SNP Microarray Testing and Analysis Product Portfolio
  102. 8.17.5 VCGS Recent Developments
  103. 8.18 Genetics Associates
  104. 8.18.1 Genetics Associates Company Information
  105. 8.18.2 Genetics Associates Business Overview
  106. 8.18.3 Genetics Associates SNP Microarray Testing and Analysis Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Genetics Associates SNP Microarray Testing and Analysis Product Portfolio
  108. 8.18.5 Genetics Associates Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst